LINCOLN PHARMACEUTICALS
|
The Current P/S Ratio of LINCOLN PHARMACEUTICALS is 1.95.
| Share Price | ₹635.1 | Feb 18,2026 |
| Market Cap | ₹1,270.2 Cr | |
| Sales-TTM | ₹651.9 Cr | TTM-Consolidated Results |
| Price/Sales | 1.95x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LINCOLN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,270.2 Cr] as on Feb 18,2026
(/) Sales [ ₹651.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.95x ]
Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '1.95 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LINCOLN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of LINCOLN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of LINCOLN PHARMACEUTICALS
PS Ratio Performance Analysis for LINCOLN PHARMACEUTICALS
- LINCOLN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.50x.
- LINCOLN PHARMACEUTICALS 's operated at median p/e ratio of 1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.02x.
- LINCOLN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.06x.
How does LINCOLN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LINCOLN PHARMACEUTICALS | 651.9 | 1.95 | 1,270.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.28 | 413,717.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.18 | 166,830.0 |
| CIPLA LTD | 28,351.1 | 3.84 | 108,978.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.18 | 142,479.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.08 | 106,905.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.16 | 85,665.3 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.51 | 91,572.3 |
| LUPIN LTD | 26,150.5 | 3.89 | 101,749.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.03 | 67,358.5 |
| ABBOTT INDIA LTD | 6,824.1 | 8.24 | 56,239.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LINCOLN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.95x |
| Max industry PS | 16.18x |
| Median industry PS | 3.89x |
| Average industry PS | 6.12x |
You may also like the below Video Courses